Deadly superbugs thrive as access to antibiotics falters in India

Deadly superbugs are spreading in India as access to antibiotics diminishes, leading to a rising threat of antimicrobial resistance. A study by the Global Antibiotic Research and Development Partnership found that only 6.9% of patients with carbapenem-resistant Gram-negative (CRGN) infections received appropriate treatment, with India dealing with a significant portion of these cases but struggling to treat them effectively. The lack of access to crucial antibiotics in low- and middle-income countries like India is contributing to a growing crisis where treatable infections are claiming lives due to a shortage of vital drugs.